GlassScriptPhysician profile
Paul Michael Kaminsky
NPI 1295173763
$42,099.32
in general payments reported to CMS, 2019-2025
14 companies · $7,047 in 2025
The $7,047 reported for 2025 was more than what 91% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $4,427 · 2021: $243 · 2022: $959 · 2023: $6,772 · 2024: $22K · 2025: $7,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $28K · Travel and Lodging: $2,628 · Consulting Fee: $2,070 · Food and Beverage: $1,996 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $28,236.45 |
| Travel and Lodging | $2,627.64 |
| Consulting Fee | $2,070.00 |
| Food and Beverage | $1,995.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $38,730.71 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $2,261.24 | 2023-2025 | Seprafilm, Peri-Strips Dry, Tisseel |
| Medtronic, INC. | $293.52 | 2022-2025 | Interstim, Sonicision |
| Boston Scientific Corporation | $169.87 | 2022 | |
| Braintree Laboratories, INC. | $143.04 | 2021 | |
| Stryker Corporation | $110.05 | 2019 | |
| Tela Bio, INC. | $100.00 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $66.67 | 2025 | Airseal |
| Ethicon US, LLC | $53.44 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $52.91 | 2020-2021 | |
| Smith+Nephew, INC. | $37.07 | 2025 | Stravix Pl |
| Covidien LP | $32.65 | 2020 | |
| Lucid Diagnostics INC. | $25.98 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kaminsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.